» Articles » PMID: 18628315

Clinical and Molecular Delineation of the 17q21.31 Microdeletion Syndrome

Abstract

Background: The chromosome 17q21.31 microdeletion syndrome is a novel genomic disorder that has originally been identified using high resolution genome analyses in patients with unexplained mental retardation.

Aim: We report the molecular and/or clinical characterisation of 22 individuals with the 17q21.31 microdeletion syndrome.

Results: We estimate the prevalence of the syndrome to be 1 in 16,000 and show that it is highly underdiagnosed. Extensive clinical examination reveals that developmental delay, hypotonia, facial dysmorphisms including a long face, a tubular or pear-shaped nose and a bulbous nasal tip, and a friendly/amiable behaviour are the most characteristic features. Other clinically important features include epilepsy, heart defects and kidney/urologic anomalies. Using high resolution oligonucleotide arrays we narrow the 17q21.31 critical region to a 424 kb genomic segment (chr17: 41046729-41470954, hg17) encompassing at least six genes, among which is the gene encoding microtubule associated protein tau (MAPT). Mutation screening of MAPT in 122 individuals with a phenotype suggestive of 17q21.31 deletion carriers, but who do not carry the recurrent deletion, failed to identify any disease associated variants. In five deletion carriers we identify a <500 bp rearrangement hotspot at the proximal breakpoint contained within an L2 LINE motif and show that in every case examined the parent originating the deletion carries a common 900 kb 17q21.31 inversion polymorphism, indicating that this inversion is a necessary factor for deletion to occur (p<10(-5)).

Conclusion: Our data establish the 17q21.31 microdeletion syndrome as a clinically and molecularly well recognisable genomic disorder.

Citing Articles

Epilepsy, EEG and chromosomal rearrangements.

Paprocka J, Coppola A, Cuccurullo C, Stawicka E, Striano P Epilepsia Open. 2024; 9(4):1192-1232.

PMID: 38837855 PMC: 11296106. DOI: 10.1002/epi4.12951.


Unraveling the complex role of MAPT-containing H1 and H2 haplotypes in neurodegenerative diseases.

Pedicone C, Weitzman S, Renton A, Goate A Mol Neurodegener. 2024; 19(1):43.

PMID: 38812061 PMC: 11138017. DOI: 10.1186/s13024-024-00731-x.


KAT8 beyond Acetylation: A Survey of Its Epigenetic Regulation, Genetic Variability, and Implications for Human Health.

Yoo L, Mendoza D, Richard A, Stephens J Genes (Basel). 2024; 15(5).

PMID: 38790268 PMC: 11121512. DOI: 10.3390/genes15050639.


A new blood DNA methylation signature for Koolen-de Vries syndrome: Classification of missense KANSL1 variants and comparison to fibroblast cells.

Awamleh Z, Choufani S, Wu W, Rots D, Dingemans A, Nadif Kasri N Eur J Hum Genet. 2024; 32(3):324-332.

PMID: 38282074 PMC: 10923882. DOI: 10.1038/s41431-024-01538-6.


Expanding the speech and language phenotype in Koolen-de Vries syndrome: late onset and periodic stuttering a novel feature.

St John M, Van Reyk O, Koolen D, de Vries B, Amor D, Morgan A Eur J Hum Genet. 2022; 31(5):531-540.

PMID: 36529818 PMC: 10172335. DOI: 10.1038/s41431-022-01230-7.


References
1.
de Vries B, van den Ouweland A, Mohkamsing S, Duivenvoorden H, Mol E, Gelsema K . Screening and diagnosis for the fragile X syndrome among the mentally retarded: an epidemiological and psychological survey. Collaborative Fragile X Study Group. Am J Hum Genet. 1997; 61(3):660-7. PMC: 1715962. DOI: 10.1086/515496. View

2.
Kirchhoff M, Bisgaard A, Duno M, Hansen F, Schwartz M . A 17q21.31 microduplication, reciprocal to the newly described 17q21.31 microdeletion, in a girl with severe psychomotor developmental delay and dysmorphic craniofacial features. Eur J Med Genet. 2007; 50(4):256-63. DOI: 10.1016/j.ejmg.2007.05.001. View

3.
Saugier-Veber P, Goldenberg A, Drouin-Garraud V, de La Rochebrochard C, Layet V, Drouot N . Simple detection of genomic microdeletions and microduplications using QMPSF in patients with idiopathic mental retardation. Eur J Hum Genet. 2006; 14(9):1009-17. DOI: 10.1038/sj.ejhg.5201661. View

4.
Slager R, Newton T, Vlangos C, Finucane B, Elsea S . Mutations in RAI1 associated with Smith-Magenis syndrome. Nat Genet. 2003; 33(4):466-8. DOI: 10.1038/ng1126. View

5.
Feuk L, Carson A, Scherer S . Structural variation in the human genome. Nat Rev Genet. 2006; 7(2):85-97. DOI: 10.1038/nrg1767. View